Fritextsökning
Innehållstyper
-
BMS och riskkapitaljätte bildar bolag för läkemedel mot autoimmuna sjukdomar
Det amerikanska läkemedelsbolaget Bristol Myers Squibb bildar tillsammans med riskkapitalbolaget Bain Capital ett nytt biotechbolag. Företaget ska utveckla beha...
-
Webinar: Automate your processes
Free ZEISS webinar on January 30th, 2025.
-
The Swedish Foundation for Strategic Research
-
Easy integration of piezo valves for gas handling
Extremely energy-saving, silent and without any heat build-up – piezo technology offers many benefits for efficient and precise gas handling in medical technolo...
-
Enhance your expertise with your measuring software
Discover the training options in our ZEISS Metrology Portal.
-
Automated nitrogen analysis reduces costs per sample
N-Realizer analytical system from C. Gerhardt increases productivity with valve block from Festo
-
Her company is developing a new tablet form obesity drug
Obesity and diabetes are the primary targets of a new tablet treatment under development by Malmö-based Pila Pharma. The company’s ambition is to take on the bi...
-
Sobi announces agreement with Enable Injections
Swedish biopharma Sobi has entered into an international development and distribution agreement with US drug delivery company Enable Injections.
-
SupraCube - In life Science
Superconductors must be permanently kept below their transition temperature for levitation. Because of the integrated cooler, applications with superconductors ...
-
MSD discontinues two Keytruda trials
MSD has stopped two late-stage trials that tested its blockbuster immunotherapy Keytruda as a treatment for skin and lung cancer.
-
Double up for Korbinian Löbmann
This year, Korbinian Löbmann will moderate the New Updates in Drug Formulation & Bioavailability meeting in Copenhagen for the fifth time. Furthermore, he will ...
-
Marie Gårdmark: “What to expect from Trump’s second term?”
One may complain about the complex multinational system in EU, but it gives us some predictability that cannot be easily overturned by different member states p...
-
Anna Törner: Yes, I Am Sick, But Not Weak
”People often say that someone who is ill only has one wish—to get better. But I think that is not true. Someone who is ill also longs to be understood, to be r...
-
Conference recordings now available
Don't miss out on insights from leading experts.
-
Lämnar tankesmedjan efter åtta år: ”Oerhört inspirerande att driva på innovation”
Catharina Barkman har under åtta år drivit den oberoende tankesmedjan Forum för Health Policy. I slutet av sommaren går hon vidare till nya utmaningar och nu bl...
-
Mastering Urine Microscopy
On-demand Webinar: Microscopy in urinalysis.
-
Several departures at the top at Nykode
Members of both the management and the board are leaving the Norwegian biotech company Nykode.
-
Takeover bid is being completed – Japanese company acquires Calliditas
Japanese company Asahi Kasei completes the bid for Calliditas Therapeutics after reaching over 90 percent of the shareholding. Callidita's board has now decided...
-
Inget statligt stöd för fetmaläkemedel – aktien för läkemedelsjättar pressas
Trump-administrationen slopar Bidens förslag om att om att inkludera fetmaläkemedel i sjukförsäkringen Medicare. Det innebär ett bakslag för Novo Nordisk och El...
-
Han är Gileads nya Nordenchef
Gilead Sciences har utsett Pau Arbos till ny till General Manager för Norden.
-
15-procentiga tullar på läkemedel – så reagerar branschen
Riktigt illa – men det kunde ha varit ännu värre. Så kan branschens reaktioner på uppgörelsen om USA:s läkemedelstullar mot EU sammanfattas.
-
High-performance Slide Scanner for Fluorescence, Brightfield and Polarization
ZEISS Axioscan 7 combines high speed digitization and outstanding image quality.
-
Controlled Pneumatics: pushing the boundaries of pneumatics
automation processes that are already known. It also opens up new opportunities, especially for controlling pressure and flow rate. Piezo valves, which enable v...
-
FDA vill ersätta djurförsök med AI – ”Paradigmskifte”
Krav på djurförsök vid läkemedelsutveckling ska fasas ut och ersättas med AI, meddelade FDA på torsdagen. Beskedet möts av skepsis från den nationella föreninge...